Fundraising Fox

EnClear Therapies

Cambridge, US · 4 known investors

encleartherapies.com ↗

EnClear Therapies develops precision drug delivery technology targeting the central nervous system for patients with CNS diseases including neuro-oncology, neurodegenerative disorders, and autoimmune conditions. The company uses its proprietary EnTrega CSF Platform to enable targeted therapeutics delivery.

BiotechDigital HealthMedical Devicesin /33238076

Founders & leadership

JF
Jonathan FlemingDirector
JC
Jason CammDirector
KR
Kasper RoetDirector
AD
Anthony DePasquaExecutive Officer, Director

Investors · 4

Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
Tachyon VenturesLos Angeles
VU Venture PartnersSan Francisco · $200K – $1M
Dolby Family VenturesreportedSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$718.3KraisedMar 2024 · 8 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan FlemingDirector
  • Jason CammDirector
  • Kasper RoetDirector
  • Anthony DePasquaExecutive Officer, Director
Offering amount
$2M
Amount sold
$718.3K
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.